- Home
- CHMI vs GALT Comparison
CHMI vs GALT Comparison
Compare CHMI & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMI
- GALT
- Stock Information
- Founded
- CHMI 2012
- GALT 2000
- Country
- CHMI United States
- GALT United States
- Employees
- CHMI N/A
- GALT N/A
- Industry
- CHMI Real Estate Investment Trusts
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- CHMI Real Estate
- GALT Health Care
- Exchange
- CHMI Nasdaq
- GALT Nasdaq
- Market Cap
- CHMI 96.3M
- GALT 83.5M
- IPO Year
- CHMI 2013
- GALT N/A
- Fundamental
- Price
- CHMI $2.96
- GALT $1.31
- Analyst Decision
- CHMI Hold
- GALT Hold
- Analyst Count
- CHMI 2
- GALT 1
- Target Price
- CHMI N/A
- GALT N/A
- AVG Volume (30 Days)
- CHMI 195.4K
- GALT 170.0K
- Earning Date
- CHMI 05-06-2025
- GALT 05-15-2025
- Dividend Yield
- CHMI 20.27%
- GALT N/A
- EPS Growth
- CHMI N/A
- GALT N/A
- EPS
- CHMI N/A
- GALT N/A
- Revenue
- CHMI $27,506,000.00
- GALT N/A
- Revenue This Year
- CHMI N/A
- GALT N/A
- Revenue Next Year
- CHMI $70.41
- GALT N/A
- P/E Ratio
- CHMI N/A
- GALT N/A
- Revenue Growth
- CHMI 19.59
- GALT N/A
- 52 Week Low
- CHMI $2.34
- GALT $0.73
- 52 Week High
- CHMI $3.99
- GALT $3.17
- Technical
- Relative Strength Index (RSI)
- CHMI 47.36
- GALT 48.59
- Support Level
- CHMI $2.93
- GALT $1.22
- Resistance Level
- CHMI $3.01
- GALT $1.36
- Average True Range (ATR)
- CHMI 0.09
- GALT 0.10
- MACD
- CHMI -0.01
- GALT -0.00
- Stochastic Oscillator
- CHMI 12.50
- GALT 29.41
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.